Published: March 2016
This advisory summarizes data on the use of sublingual and transmucosal buprenorphine for the medication-assisted treatment of opioid use disorder.
Millions of Americans have a substance use disorder. Find a treatment facility near you.
Free and confidential support for people in distress, 24/7.
Find treatment facilities confidentially and anonymously, 24/7.
Treatment referral and information, 24/7.
Visit the SAMHSA Facebook page
Visit SAMHSA on Twitter
Visit the SAMHSA YouTube channel
Visit SAMHSA on LinkedIn
Visit SAMHSA on Instagram
To sign up for updates or to access your subscriber preferences, please enter your contact information.
Have a question about government service? Contact USA.gov.